Hugues Loiseau
- Genetics top 0.5%
- Glioma Diagnosis and Treatment 40
- Neurology top 1%
- Neurofibromatosis and Schwannoma Cases 9
- CNS Lymphoma Diagnosis and Treatment 6
- Neuroblastoma Research and Treatments 5
- Epidemiology top 2%
- Meningioma and schwannoma management 29
- Biophysics top 2%
-
- Pituitary Gland Disorders and Treatments 14
-
- Brain Metastases and Treatment 10
-
- Head and Neck Surgical Oncology 7
- Co-authors
- Isabelle BaldiAnne VitalGuy KantorJean‐Sébastien GuillamoPierre LebaillyPhilippe MeneïKarima MokhtariLuc Taillandier
- Cited by
- GeneticsNeurologyEpidemiology
- Journals
- New England Journal of Medicine (1 paper)The Journal of Clinical Endocrinology & Metabolism (1 paper)International Journal of Molecular Sciences (1 paper)
- Partner nations
- FranceUnited StatesBelize
In The Last Decade
Hugues Loiseau
95 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Genetics 1.2k
- Neurology 802
- Epidemiology 1.1k
- Biophysics 175
- Endocrinology, Diabetes and Metabolism 447
Countries citing papers authored by Hugues Loiseau
This map shows the geographic impact of Hugues Loiseau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugues Loiseau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugues Loiseau more than expected).
Fields of papers citing papers by Hugues Loiseau
This network shows the impact of papers produced by Hugues Loiseau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugues Loiseau. The network helps show where Hugues Loiseau may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hugues Loiseau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 4 | |
| 2 | 2022 | 4 | |
| 3 | 2020 | 23 | |
| 4 | 2018 | 20 | |
| 5 | 2017 | 65 | |
| 6 | 2016 | 26 | |
| 7 | 2016 | 8 | |
| 8 | 2013 | 54 | |
| 9 | 2011 | 112 | |
| 10 | 2011 | 52 | |
| 11 | 2010 | 60 | |
| 12 | 2010 | 14 | |
| 13 | 2009 | 33 | |
| 14 | 2009 | 20 | |
| 15 | 2007 | 31 | |
| 16 | 2002 | 3 | |
| 17 | Expression of somatostatin receptor subtypes 2 and 5 in human prolactinomas | 1999 | 1 |
| 18 | Dopamine D2 receptor gene expression in growth hormone-producing pituitary adenomas | 1996 | 1 |
| 19 | 1996 | 20 | |
| 20 | 1995 | 43 |
About Hugues Loiseau
Hugues Loiseau is a scholar working on Genetics, Neurology and Endocrinology, Diabetes and Metabolism, having authored 97 papers that have together received 3.1k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (40 papers), Meningioma and schwannoma management (29 papers), Pituitary Gland Disorders and Treatments (14 papers), Brain Metastases and Treatment (10 papers), Neurofibromatosis and Schwannoma Cases (9 papers), Head and Neck Surgical Oncology (7 papers), CNS Lymphoma Diagnosis and Treatment (6 papers) and Neuroblastoma Research and Treatments (5 papers). The work is most often cited by research in Genetics (1.2k citations), Neurology (802 citations) and Epidemiology (1.1k citations). Hugues Loiseau has collaborated with scholars based in France, United States and Belize. Frequent co-authors include Isabelle Baldi, Anne Vital, Guy Kantor, Jean‐Sébastien Guillamo, Pierre Lebailly, Philippe Meneï, Karima Mokhtari, Luc Taillandier, Jean‐Yves Delattre and Olivier Chinot. Their work appears in journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.